Treatment of malignant endocrine pancreatic tumors with a combination of α-interferon and somatostatin analogs

By Fjällskog M.-L.   Sundin A.   Westlin J.-E.   Öberg K.   Janson E.   Eriksson B.  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 35-42

Humana Press, Inc

Access to resources Recommend Favorite

Parenchyma-Preserving Resections for Small Nonfunctioning Pancreatic Endocrine Tumors

By Falconi Massimo  

Annals of Surgical Oncology, Vol. 17, Iss. 6, 2010-06 ,pp. : 1621-1627

Springer Publishing Company

Access to resources Recommend Favorite

Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas

By Fjällskog Marie-Louise   Hessman Ola   Eriksson Barbro   Janson Eva Tiensuu  

Acta Oncologica, Vol. 46, Iss. 6, 2007-01 ,pp. : 741-746

Informa Healthcare

Access to resources Recommend Favorite

Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years

By Kindmark Henrik   Sundin Anders   Granberg Dan   Dunder Kristina   Skogseid Britt   Janson Eva   Welin Staffan   Öberg Kjell   Eriksson Barbro  

Medical Oncology, Vol. 24, Iss. 3, 2007-09 ,pp. : 330-337

Humana Press, Inc

Access to resources Recommend Favorite

Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors

By Fjällskog Marie-Louise   Ludvigsen Eva   Stridsberg Mats   Öberg Kjell   Eriksson Barbro   Janson Eva  

Medical Oncology, Vol. 20, Iss. 1, 2003-03 ,pp. : 59-67

Humana Press, Inc

Access to resources Recommend Favorite